Patents by Inventor Kristin B. Hendricks

Kristin B. Hendricks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8404816
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: March 26, 2013
    Assignee: Epitomics, Inc.
    Inventors: Fernando Jose Rebelo Do Couto, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu
  • Publication number: 20120329069
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Application
    Filed: August 10, 2012
    Publication date: December 27, 2012
    Inventors: Fernando Jose Rebelo Do Couto, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu
  • Publication number: 20120003671
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Application
    Filed: May 3, 2011
    Publication date: January 5, 2012
    Inventors: Fernando Jose Rebelo Do Couto, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu
  • Patent number: 7960517
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: June 14, 2011
    Assignee: Epotimics, Inc.
    Inventors: Fernando Jose Rebelo Do Couto, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu
  • Publication number: 20090155824
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Application
    Filed: October 31, 2008
    Publication date: June 18, 2009
    Inventors: FERNANDO JOSE REBELO DO COUTO, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu
  • Patent number: 7462697
    Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: December 9, 2008
    Assignee: Epitomics, Inc.
    Inventors: Fernando Jose Rebelo Do Couto, Kristin B. Hendricks, S. Ellen Wallace, Guo-Liang Yu